LUNG NON-SQUAMOUS NON-SMALL CELL CARCINOMA
Clinical trials for LUNG NON-SQUAMOUS NON-SMALL CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new LUNG NON-SQUAMOUS NON-SMALL CELL CARCINOMA trials appear
Sign up with your email to follow new studies for LUNG NON-SQUAMOUS NON-SMALL CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New study tests best order of immunotherapy and chemo for lung cancer
Disease control OngoingThis phase 3 trial studies the best way to use immunotherapy (pembrolizumab) and chemotherapy for advanced non-squamous non-small cell lung cancer. About 600 participants receive either immunotherapy alone first, then chemo with or without immunotherapy later, or a combination of…
Matched conditions: LUNG NON-SQUAMOUS NON-SMALL CELL CARCINOMA
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 22, 2026 14:03 UTC
-
Lung cancer pill after surgery shows promise in targeted trial
Disease control OngoingThis study tests whether taking erlotinib (a daily pill that blocks cancer growth signals) after surgery helps people with a specific type of lung cancer (EGFR-mutant) live longer compared to just watching and waiting. About 390 participants who had their lung cancer completely r…
Matched conditions: LUNG NON-SQUAMOUS NON-SMALL CELL CARCINOMA
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 20, 2026 11:57 UTC